GLI2 and neoplasm: We established a role for both TGF-β signaling and GLI2 in driving melanoma invasion and metastasis, that could be targeted with TGF-β receptor inhibitors, the latter inhibiting GLI2 expression in tumor cells, or by knocking down GLI2 expression14–16.